metoprolol has been researched along with Coxsackie Virus Infections in 5 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis." | 7.74 | Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008) |
| "In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated." | 7.73 | Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. ( Chandrasekharan, K; Li, J; Noutsias, M; Pauschinger, M; Peter Schwimmbeck, L; Poller, W; Rutschow, S; Schultheiss, HP; Tschope, C; Weitz, A; Westermann, D; Zeichhardt, H, 2005) |
| "Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis." | 7.72 | Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. ( Noutsias, M; Pauschinger, M; Rutschow, S; Schultheiss, HP; Schwimmbeck, PL; Steendijk, P; Tschöpe, C; Weitz, A; Westermann, D, 2004) |
| "Treatment with metoprolol reduced insignificantly the viral load and body weight loss (experiment A and B) but led to a significant reduction of myocardial histopathology in experiment A." | 5.36 | Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis. ( Dahlke, K; Decker, M; Glück, B; Krumbholz, A; Lehmann, J; Wutzler, P; Zell, R, 2010) |
| "Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis." | 3.74 | Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008) |
| "In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated." | 3.73 | Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. ( Chandrasekharan, K; Li, J; Noutsias, M; Pauschinger, M; Peter Schwimmbeck, L; Poller, W; Rutschow, S; Schultheiss, HP; Tschope, C; Weitz, A; Westermann, D; Zeichhardt, H, 2005) |
| "Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis." | 3.72 | Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. ( Noutsias, M; Pauschinger, M; Rutschow, S; Schultheiss, HP; Schwimmbeck, PL; Steendijk, P; Tschöpe, C; Weitz, A; Westermann, D, 2004) |
| "Treatment with metoprolol reduced insignificantly the viral load and body weight loss (experiment A and B) but led to a significant reduction of myocardial histopathology in experiment A." | 1.36 | Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis. ( Dahlke, K; Decker, M; Glück, B; Krumbholz, A; Lehmann, J; Wutzler, P; Zell, R, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glück, B | 1 |
| Dahlke, K | 1 |
| Zell, R | 1 |
| Krumbholz, A | 1 |
| Decker, M | 1 |
| Lehmann, J | 1 |
| Wutzler, P | 1 |
| Tschöpe, C | 2 |
| Westermann, D | 2 |
| Steendijk, P | 1 |
| Noutsias, M | 2 |
| Rutschow, S | 2 |
| Weitz, A | 2 |
| Schwimmbeck, PL | 1 |
| Schultheiss, HP | 2 |
| Pauschinger, M | 2 |
| Chandrasekharan, K | 1 |
| Peter Schwimmbeck, L | 1 |
| Zeichhardt, H | 1 |
| Poller, W | 1 |
| Li, J | 1 |
| Yue-Chun, L | 1 |
| Li-Sha, G | 1 |
| Jiang-Hua, R | 1 |
| Peng-Lin, Y | 1 |
| Jia-Feng, L | 1 |
| Ji-Fei, T | 1 |
| Peng, C | 1 |
| Zhan-Qiu, Y | 1 |
| Rezkalla, S | 1 |
| Kloner, RA | 1 |
| Khatib, G | 1 |
| Smith, FE | 1 |
| Khatib, R | 1 |
5 other studies available for metoprolol and Coxsackie Virus Infections
| Article | Year |
|---|---|
Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Coxsackievirus Infections; Enterovirus B, Human; He | 2010 |
Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol.
Topics: Animals; Carbazoles; Carvedilol; Coxsackievirus Infections; Male; Metoprolol; Mice; Mice, Inbred BAL | 2004 |
Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Coxsackievirus Infections; Interleukin | 2005 |
Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Carbazo | 2008 |
Effect of metoprolol in acute coxsackievirus B3 murine myocarditis.
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Metoprolol; Mice; Myocarditis; Myocardium | 1988 |